Elanco Animal Health (ELAN) Financials: Revenue & Earnings
ELAN$23.17+0.52 +2.30%
$11.57B
Market Cap
-55.24
P/E
20.46
Forward P/E
46
Score
Elanco Animal Health (ELAN) Financials: Revenue & Earnings
ELAN price $23.17 +0.52 +2.30%
- Ticker
- ELAN
- Price
- $23.17
- Change
- +0.52 +2.30%
- Market cap ?
- $11.57B
- P/E ?
- -55.24
- Forward P/E ?
- 20.46
- Dividend yield ?
- 0.00%
- Beta ?
- 1.71
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stocklytics score
- 46
- Value
- 44
- Quality
- 42
- Growth
- 52
Stocklytics score rationale: value 44, quality 42, growth 52.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2913500000 | 2889000000 | 3066800000 | 3071000000 | 3273300000 | 4764000000 | 4411000000 | 4417000000 | 4439000000 | 4715000000 |
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and…
Earnings and financials
Elanco Animal Health Incorporated (ELAN) trades at $23.17, with a market cap of $11.57B and a trailing P/E of -55.24. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 2913500000 | 2889000000 | 3066800000 | 3071000000 | 3273300000 | 4764000000 | 4411000000 | 4417000000 | 4439000000 | 4715000000 |
Insights · Dividends · Forecast · Financials · Learn